FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:1734-1739 December 5, 1996 Number 23 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Recent research on academic–industrial research relationships in the life sciences has examined their frequency, benefits, risks, and evolution from the standpoint of industrial sponsors of research. We collected information on the extent and effects of academic–industrial research relationships from the standpoint of faculty members who participate in them.

Methods We used a mailed questionnaire to collect data between October 1994 and April 1995 from 2052 faculty members (of 3169 eligible respondents; response rate, 65 percent) in the life sciences at the 50 U.S. universities receiving the most research funding from the National Institutes of Health.

Results Twenty-eight percent of the respondents received research support from industry. Faculty members receiving industrial funds had more peer-reviewed articles published in the previous three years, participated in more administrative activities in their institutions or disciplines, and were more commercially active than faculty members without such funding. However, faculty members receiving more than two thirds of their research support from industry were less academically productive than those receiving a lower level of industrial support, and their articles were less influential than those by researchers with no industrial support. Faculty members with industrial support were significantly more likely than those without industrial support to report that trade secrets had resulted from their work (14.5 percent vs. 4.7 percent, P<0.001) and that they had taken commercial considerations into account when choosing research topics (35 percent vs. 14 percent, P<0.001).

Conclusions Faculty members with industrial research support are at least as productive academically as those without such support and are more productive commercially. However, faculty members who have research relationships with industry are more likely to restrict their communication with colleagues, and high levels of industrial support may be associated with less academic activity without evidence of proportional increases in commercial productivity.

Source Information

From the Health Policy Research and Development Unit, Division of General Internal Medicine, Massachusetts General Hospital, Boston (D.B., E.G.C., N.C.); the Departments of Medicine (D.B., N.C.) and Health Care Policy (D.B.), Harvard Medical School, Boston; and the College of Education, University of Minnesota, Minneapolis (K.S.L.).

Address reprint requests to Dr. Blumenthal at the Health Policy Research and Development Unit, 50 Staniford St., Boston, MA 02114.

Full Text of this Article

This article has been cited by other articles:

• Merry, A. F. (2008). Ethics, Industry, and Outcomes. SEMIN CARDIOTHORAC VASC ANESTH 12: 7-11 [Abstract]  
• Bercovitz, J., Feldman, M. (2008). Academic Entrepreneurs: Organizational Change at the Individual Level. Organization Science 19: 69-89 [Abstract]  
• Yank, V., Rennie, D., Bero, L. A (2007). Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study. BMJ 335: 1202-1205 [Abstract] [Full Text]  
• Hampson, L. A., Joffe, S., Fowler, R., Verter, J., Emanuel, E. J. (2007). Frequency, Type, and Monetary Value of Financial Conflicts of Interest in Cancer Clinical Research. JCO 25: 3609-3614 [Abstract] [Full Text]  
• Campbell, E. G., Weissman, J. S., Vogeli, C., Clarridge, B. R., Abraham, M., Marder, J. E., Koski, G. (2006). Financial Relationships between Institutional Review Board Members and Industry. NEJM 355: 2321-2329 [Abstract] [Full Text]  
• Jacobs, J. J., Galante, J. O., Mirza, S. K., Zdeblick, T. (2006). Symposium. Relationships with Industry: Critical for New Technology or an Unnecessary Evil?. JBJS 88: 1650-1663 [Full Text]  
• Becker, G. J. (2006). Financial Relationships with Industry and Device Research Involving Non-Food and Drug Administration-approved Use: A Perspective.. Radiology 239: 626-628 [Full Text]  
• Brown, S. D., Daly, J. C., Kalish, L. A., McDaniel, S. A. (2006). Financial Disclosures of Scientific Papers Presented at the 2003 RSNA Annual Meeting: Association with Reporting of Non-Food and Drug Administration-approved Uses of Industry Products. Radiology 239: 849-855 [Abstract] [Full Text]  
• Mirowski, P., Van Horn, R. (2005). The Contract Research Organization and the Commercialization of Scientific Research. Social Studies of Science 35: 503-548 [Abstract]  
• Lexchin, J. R (2005). Implications of Pharmaceutical Industry Funding on Clinical Research. The Annals of Pharmacotherapy 39: 194-197 [Abstract] [Full Text]  
• Helft, P. R., Ratain, M. J., Epstein, R. A., Siegler, M. (2004). Inside Information: Financial Conflicts of Interest for Research Subjects in Early Phase Clinical Trials. JNCI J Natl Cancer Inst 96: 656-661 [Abstract] [Full Text]  
• Kim, S Y H, Millard, R W, Nisbet, P, Cox, C, Caine, E D (2004). Potential research participants' views regarding researcher and institutional financial conflicts of interest. J. Med. Ethics 30: 73-79 [Abstract] [Full Text]  
• Blumenthal, D. (2003). Academic-Industrial Relationships in the Life Sciences. NEJM 349: 2452-2459 [Full Text]  
• Bekelman, J. E., Li, Y., Gross, C. P. (2003). Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review. JAMA 289: 454-465 [Abstract] [Full Text]  
• Campbell, E. G., Clarridge, B. R., Gokhale, M., Birenbaum, L., Hilgartner, S., Holtzman, N. A., Blumenthal, D. (2002). Data Withholding in Academic Genetics: Evidence From a National Survey. JAMA 287: 473-480 [Abstract] [Full Text]  
• Gelijns, A. C., Thier, S. O. (2002). Medical Innovation and Institutional Interdependence: Rethinking University-Industry Connections. JAMA 287: 72-77 [Abstract] [Full Text]  
• Kneller, R. (2001). Technology Transfer: A Review for Biomedical Researchers. Clin. Cancer Res. 7: 761-774 [Abstract] [Full Text]  
• Cho, M. K., Shohara, R., Schissel, A., Rennie, D. (2000). Policies on Faculty Conflicts of Interest at US Universities. JAMA 284: 2203-2208 [Abstract] [Full Text]  
• Boyd, E. A., Bero, L. A. (2000). Assessing Faculty Financial Relationships With Industry: A Case Study. JAMA 284: 2209-2214 [Abstract] [Full Text]  
• Weissman, J. S., Saglam, D., Campbell, E. G., Causino, N., Blumenthal, D. (1999). Market Forces and Unsponsored Research in Academic Health Centers. JAMA 281: 1093-1098 [Abstract] [Full Text]  
• Krimsky, S., Rothenberg, L. S. (1998). Financial Interest and Its Disclosure in Scientific Publications. JAMA 280: 225-226 [Abstract] [Full Text]  
• Campbell, E. G., Louis, K. S., Blumenthal, D. (1998). Looking a Gift Horse in the Mouth: Corporate Gifts Supporting Life Sciences Research. JAMA 279: 995-999 [Abstract] [Full Text]